A dual brain-targeting curcumin-loaded polymersomes ameliorated cognitive dysfunction in intrahippocampal amyloid-β_1–42-injected mice

References

• DischerDEEisenbergAPolymer vesiclesScience2002297558396797312169723
   PubMed Web of Science ®Google Scholar
• LeeJSFeijenJPolymersomes for drug delivery: design, formation and characterizationJ Control Release2012161247348322020381
   PubMed Web of Science ®Google Scholar
• DischerBMWonYYEgeDSPolymersomes: tough vesicles made from diblock copolymersScience199928454171143114610325219
   PubMed Web of Science ®Google Scholar
• WortmannMDementia: a global health priority-highlights from an ADI and world health organization reportAlzheimers Res Ther2012454022995353
   PubMed Web of Science ®Google Scholar
• HardyJThe amyloid hypothesis for Alzheimer’s disease: a critical reappraisalJ Neurochem200911041129113419457065
   PubMed Web of Science ®Google Scholar
• AggarwalBBSungBPharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targetsTrends Pharmacol Sci2009302859419110321
   PubMed Web of Science ®Google Scholar
• LimGPChuTYangFThe curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouseJ Neurosci200121218370837711606625
   PubMed Web of Science ®Google Scholar
• PakYPatekRMayersohnMSensitive and rapid isocratic liquid chromatography method for the quantitation of curcumin in plasmaJ Chromatogr B Analyt Technol Biomed Life Sci20037962339346
   Web of Science ®Google Scholar
• OnoKNaikiHYamadaMThe development of preventives and therapeutics for Alzheimer’s disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbetaCurr Pharm Des200612334357437517105432
   PubMed Web of Science ®Google Scholar
• SunMSuXDingBAdvances in nanotechnology-based delivery systems for curcuminNanomedicine (Lond)2012771085110022846093
   PubMed Web of Science ®Google Scholar
• MisraRSahooSKCoformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cellsMol Pharm20118385286621480667
   PubMed Web of Science ®Google Scholar
• StamatovicSMKeepRFAndjelkovicAVBrain endothelial cell-cell junctions: how to “open” the blood brain barrierCurr Neuropharmacol20086317919219506719
   PubMed Web of Science ®Google Scholar
• PardridgeWMDrug and gene targeting to the brain with molecular Trojan horsesNat Rev Drug Discov20021213113912120094
   PubMed Web of Science ®Google Scholar
• Paris-RobidasSEmondVTremblayCIn vivo labeling of brain capillary endothelial cells after intravenous injection of monoclonal antibodies targeting the transferrin receptorMol Pharmacol2011801323921454448
   PubMed Web of Science ®Google Scholar
• PangZGaoHYuYEnhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicinBioconjug Chem20112261171118021528923
   PubMed Web of Science ®Google Scholar
• ChenCFuZKimJJBarbieriJTBaldwinMRGangliosides as high affinity receptors for tetanus neurotoxinJ Biol Chem200928439265692657719602728
   PubMed Web of Science ®Google Scholar
• TownsendSAEvronyGDGuFXTetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neuronsBiomaterials200728345176518417854886
   PubMed Web of Science ®Google Scholar
• KwonEJLasieneJJacobsonBETargeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zoneBiomaterials20103182417242420004466
   PubMed Web of Science ®Google Scholar
• LiuJKTengQGarrity-MosesMA novel peptide defined through phage display for therapeutic protein and vector neuronal targetingNeurobiol Dis200519340741816023583
   PubMed Web of Science ®Google Scholar
• BhattacharyyaSKhanJACurranGLEfficient delivery of gold nanoparticles by dual receptor targetingAdv Mater201123435034503821971980
   PubMed Web of Science ®Google Scholar
• GaoHLPanSQYangZA cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 proteinBiomaterials201132338669867521843903
   PubMed Web of Science ®Google Scholar
• YuYPangZLuWSelf-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain deliveryPharm Res2012291839621979908
   PubMed Web of Science ®Google Scholar
• LiXTJuRJLiXYMultifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cellsOncotarget20145156497651125153726
   PubMedGoogle Scholar
• WuJZhaoJZhangBPolyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effectInt J Nanomedicine201495261527125419130
   PubMed Web of Science ®Google Scholar
• DouvilleNJTungYCLiRFabrication of two-layered channel system with embedded electrodes to measure resistance across epithelial and endothelial barriersAnal Chem20108262505251120178370
   PubMed Web of Science ®Google Scholar
• ChereddyKKCocoRMemvangaPBCombined effect of PLGA and curcumin on wound healing activityJ Control Release2013171220821523891622
   PubMed Web of Science ®Google Scholar
• GaoYLiZSunMPreparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizerDrug Dev Ind Pharm201036101225123420545506
   PubMed Web of Science ®Google Scholar
• HuwylerJWuDFPardridgeWMBrain drug delivery of small molecules using immunoliposomesPNAS19969314164141698943078
   PubMed Web of Science ®Google Scholar
• PangZQLuWGaoHLPreparation and brain delivery property of biodegradable polymersomes conjugated with OX26J Control Release200812812012718436327
   PubMed Web of Science ®Google Scholar
• LeeHEKimDHParkSJNeuroprotective effect of sinapic acid in a mouse model of amyloid β(1–42) protein-induced Alzheimer’s diseasePharmacol Biochem Behav2012103226026622971592
   PubMed Web of Science ®Google Scholar
• BrouilletteJCaillierezRZommerNNeurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1–42 oligomers are revealed in vivo by using a novel animal modelJ Neurosci201232237852786122674261
   PubMed Web of Science ®Google Scholar
• MoonMChoiJGNamDWGhrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-β1–42 oligomer-injected miceJ Alzheimers Dis201123114715920930280
   PubMed Web of Science ®Google Scholar
• YuYJiangXGongSThe proton permeability of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood-brain barrier after modification with lactoferrinNanoscale2014663250325824503971
   PubMed Web of Science ®Google Scholar
• VorheesCVWilliamsMTMorris water maze: procedures for assessing spatial and related forms of learning and memoryNat Protoc20061284885817406317
   PubMed Web of Science ®Google Scholar
• BrozPBenitoSMSawCCell targeting by a generic receptor-targeted polymer nanocontainer platformJ Control Release2005102247548815653165
   PubMed Web of Science ®Google Scholar
• KurapatiKRAtluriVSSamikkannuTAshwagandha (Withania somnifera) reverses β-amyloid1–42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND)PLoS One2013810115
   Web of Science ®Google Scholar
• Serrano-PozoAFroschMPMasliahEHymanBTNeuropathological alterations in Alzheimer diseaseCold Spring Harb Perspect Med201111123
   Web of Science ®Google Scholar
• BidrosDSVogelbaumMANovel drug delivery strategies in neurooncologyNeurotherapeutics20096353954619560743
   PubMed Web of Science ®Google Scholar
• Bromley-BritsKDengYSongWMorris water maze test for learning and memory deficits in Alzheimer’s disease model miceJ Vis Exp2011205315
   Google Scholar